Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) — Capital Reinvestment Ratio
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a Capital Reinvestment Ratio of 0.09x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥670.83 Million) in capital expenditures (CN¥63.68 Million). Check 688578 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Allist Pharmaceuticals Co. Ltd. A Capital Reinvestment Ratio (2017–2025)
This chart tracks Shanghai Allist Pharmaceuticals Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see Shanghai Allist Pharmaceuticals Co. Ltd. operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Shanghai Allist Pharmaceuticals Co. Ltd. A (2017–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Allist Pharmaceuticals Co. Ltd. A from 2017 to 2025. See how much free cash does Shanghai Allist Pharmaceuticals Co. Ltd. generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | CN¥2.32 Billion | CN¥186.00 Million | ▼ -53.6% |
| 2024 | 0.17x | CN¥1.57 Billion | CN¥270.22 Million | ▲ +71.5% |
| 2023 | 0.10x | CN¥674.65 Million | CN¥67.88 Million | ▼ -93.6% |
| 2022 | 1.57x | CN¥91.63 Million | CN¥143.83 Million | ▼ -76.1% |
| 2021 | 6.56x | CN¥29.29 Million | CN¥192.25 Million | ▲ +4656.5% |
| 2017 | 0.14x | CN¥10.11 Million | CN¥1.40 Million | — |